Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Liquidia Technologies, Inc.

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™
From Liquidia Technologies, Inc.
Via GlobeNewswire
Tickers LQDA
Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD
From Liquidia Technologies, Inc.
Via GlobeNewswire
Tickers LQDA
U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
From Liquidia Technologies, Inc.
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference
From Liquidia Technologies, Inc.
Via GlobeNewswire
Tickers LQDA
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.